Virus therapy tested to shrink tough tumors before surgery
NCT ID NCT04599062
Summary
This study is testing whether injecting a modified virus (talimogene laherparepvec) directly into a tumor, along with standard radiation therapy, is safe and effective for patients with advanced soft tissue sarcoma before they have surgery. The goal is to see if this combination can kill more of the tumor cells to make surgery more successful. The study will enroll adults with certain types of advanced sarcoma that are difficult to remove completely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.